ARS Pharmaceuticals, Inc. (SPRY)
9.01
-0.06
(-0.66%)
USD |
NASDAQ |
Jun 01, 09:50
ARS Pharmaceuticals Total Liabilities (Quarterly) : 226.26M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Ironwood Pharmaceuticals, Inc. | 651.71M |
| Heron Therapeutics, Inc. | 237.08M |
| ACADIA Pharmaceuticals, Inc. | 357.16M |
| Alnylam Pharmaceuticals, Inc. | 4.054B |
| Anika Therapeutics, Inc. | 45.49M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 287.57M |
| Shareholders Equity (Quarterly) | 61.31M |
| Debt to Equity Ratio | 1.584 |
| Current Ratio | 4.943 |
| Net Debt Paydown Yield | -2.43% |